Maricel Apuli, Chief Accounting Officer at BridgeBio Pharma, Inc. (BBIO), sold 2,000 shares at $66.00 ($132K) on 2026-02-26, disclosed to the SEC on 2026-02-27.
Scheduled sale ($132k) by Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BBIO | SELL | 2026-02-18 | $38K | — | Filing → |
| BBIO | SELL | 2025-12-10 | $149K | — | Filing → |
| BBIO | SELL | 2025-08-11 | $45K | — | Filing → |